Prostaglandin E2 and cancer: insight into tumor progression and immunity

F Finetti, C Travelli, J Ercoli, G Colombo, E Buoso… - Biology, 2020 - mdpi.com
Simple Summary Inflammation is assessed as a hallmark of cancer and it is now widely
recognized that there exists a direct causal link between inflammation and tumors. Among …

Protease-activated receptors in health and disease

CJ Peach, LE Edgington-Mitchell… - Physiological …, 2023 - journals.physiology.org
Proteases are signaling molecules that specifically control cellular functions by cleaving
protease-activated receptors (PARs). The four known PARs are members of the large family …

The anti-inflammatory effects of vitamin D in tumorigenesis

W Liu, L Zhang, HJ Xu, Y Li, CM Hu, JY Yang… - International journal of …, 2018 - mdpi.com
In conjunction with the classical functions of regulating intestinal, bone, and kidney calcium
and phosphorus absorption, as well as bone mineralization of vitamin D, the population …

[PDF][PDF] Prostaglandin pathways: opportunities for cancer prevention and therapy

Q Wang, RJ Morris, AM Bode, T Zhang - Cancer research, 2022 - AACR
Because of profound effects observed in carcinogenesis, prostaglandins (PGs),
prostaglandin-endoperoxide synthases, and PG receptors are implicated in cancer …

The roles of the COX2/PGE2/EP axis in therapeutic resistance

D Tong, Q Liu, L Wang, Q Xie, J Pang, Y Huang… - Cancer and Metastasis …, 2018 - Springer
Therapeutic resistance has been and remains to be the major challenge in developing
successful treatments for different cancers and therefore, understanding the underlying …

Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner

Z Qin, C Xiang, F Zhong, Y Liu, Q Dong, K Li… - Journal of Experimental …, 2019 - Springer
Background Metabolic reprogramming is one of the hallmarks of cancer cells. The pentose
phosphate pathway (PPP), a branch of glycolysis, is an important metabolic pathway for the …

[HTML][HTML] Frontiers of ctDNA, targeted therapies, and immunotherapy in non-small-cell lung cancer

C Zhu, W Zhuang, L Chen, W Yang… - Translational lung cancer …, 2020 - ncbi.nlm.nih.gov
Non-small-cell lung cancer (NSCLC), a main subtype of lung cancer, is one of the most
common causes of cancer death in men and women worldwide. Circulating tumor DNA …

E3 ubiquitin ligase OsPIE3 destabilises the B‐lectin receptor‐like kinase PID2 to control blast disease resistance in rice

K Wang, S Li, L Chen, H Tian, C Chen, Y Fu… - New …, 2023 - Wiley Online Library
Previous studies have reported that PID2, which encodes a B‐lectin receptor‐like kinase, is
a key gene in the resistance of rice to Magnaporthe oryzae strain ZB15. However, the PID2 …

Cooperation between prostaglandin E2 and epidermal growth factor receptor in cancer progression: A dual target for cancer therapy

F Finetti, L Paradisi, C Bernardi, M Pannini, L Trabalzini - Cancers, 2023 - mdpi.com
Simple Summary Inflammation is the biological response of the body to damaging and toxic
stimuli, and is a positive event that evolves with the resolution of critical events (acute …

Effect of concomitant use of analgesics on prognosis in patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

Z Mao, X Jia, P Jiang, Q Wang, Y Zhang, Y Li… - Frontiers in …, 2022 - frontiersin.org
Background Drug–drug interactions (DDIs) pose new challenges beyond traditional
pharmacodynamics in the context of optimizing the treatment options with immune …